Regen BioPharma annual debt-to-assets ratio
2016
2018
2022
2023
2024
2025
Regen BioPharma Debt-to-Assets Ratio Growth & History (RGBP)
Regen BioPharma's debt-to-assets ratio was 3.77 for fiscal 2025.
View full Regen BioPharma company overviewRegen BioPharma annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 3.77 | 0.67 | +21.59% |
| 2024 | 2024-09-30 | 3.10 | 0.97 | +45.31% |
| 2023 | 2023-09-30 | 2.14 | −0.14 | −6.30% |
| 2022 | 2022-09-30 | 2.28 | — | — |
| 2018 | 2018-09-30 | 1.67 | — | — |
| 2016 | 2016-09-30 | 0.34 | — | — |
Regen BioPharma quarterly debt-to-assets ratio
Q2.16
Q3.16
Q4.16
Q4.18
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 2.54 | −2.73 | −51.80% |
| Q2 2026 | 2026-03-31 | 3.19 | −2.52 | −44.13% |
| Q1 2026 | 2025-12-31 | 4.08 | — | — |
| Q4 2025 | 2025-09-30 | 3.77 | 0.67 | +21.59% |
| Q3 2025 | 2025-06-30 | 5.26 | — | — |
| Q2 2025 | 2025-03-31 | 5.71 | — | — |
| Q4 2024 | 2024-09-30 | 3.10 | — | — |
| Q4 2018 | 2018-09-30 | 1.67 | — | — |
| Q4 2016 | 2016-09-30 | 0.34 | — | — |
| Q3 2016 | 2016-06-30 | 0.41 | — | — |
| Q2 2016 | 2016-03-31 | 0.52 | — | — |
Regen BioPharma debt-to-assets ratio trends
Between the periods ended 2016-09-30 and 2025-09-30, Regen BioPharma's debt-to-assets ratio increased from 0.34 to 3.77, a change of 3.44. The latest reported quarter, Q3 2026, shows 2.54.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regen BioPharma source filings ↗